Cargando…
Treatment with anticancer drugs for advanced pancreatic cancer: a systematic review
BACKGROUND: Patients with advanced pancreatic cancer have a poor prognosis and high burden of cancer-related symptoms. It is necessary to assess the trade-off of clinical benefits and possible harms of treatments with anticancer drugs (TAD). This systematic review aims to compare the effectiveness o...
Autores principales: | Salazar, Josefina, Bracchiglione, Javier, Savall-Esteve, Olga, Antequera, Alba, Bottaro-Parra, David, Gutiérrez-Valencia, Marta, Martínez-Peralta, Susana, Pericay, Carles, Tibau, Ariadna, Bonfill, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10422698/ https://www.ncbi.nlm.nih.gov/pubmed/37573294 http://dx.doi.org/10.1186/s12885-023-11207-4 |
Ejemplares similares
-
Anticancer Drugs Compared to No Anticancer Drugs in Patients with Advanced Hepatobiliary Cancer: A Mapping Review and Evidence Gap Map
por: Requeijo, Carolina, et al.
Publicado: (2023) -
Systemic Oncological Treatments versus Supportive Care for Patients with Advanced Hepatobiliary Cancers: An Overview of Systematic Reviews
por: Bracchiglione, Javier, et al.
Publicado: (2023) -
Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map
por: Salazar, Josefina, et al.
Publicado: (2023) -
Impact of COVID-19 pandemic on health care attention on breast cancer patients
por: Bruning González, P, et al.
Publicado: (2023) -
Frequency of anticancer drug use at the end of life: a scoping review
por: Szigethy, Endre, et al.
Publicado: (2023)